Inga Koneczny

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 Disease.

Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 13, 2026

Efgartigimod for Fetal Acetylcholine Receptor Antibody-Related Disorder.

Efgartigimod for Fetal Acetylcholine Receptor Antibody-Related Disorder.

Journal: The New England journal of medicine

Published: January 21, 2026

Complement deposition, IgG subtyping and endplate destruction in LRP4-ab-positive myasthenia gravis.

Complement deposition, IgG subtyping and endplate destruction in LRP4-ab-positive myasthenia gravis.

Journal: Acta neuropathologica communications

Published: December 19, 2025

Screening for Congenital Myasthenic Syndromes in Adults With Seronegative Myasthenia Gravis Using Next-Generation Sequencing.

Screening for Congenital Myasthenic Syndromes in Adults With Seronegative Myasthenia Gravis Using Next-Generation Sequencing.

Journal: Neurology

Published: September 26, 2025

IgG Subclass (IgG1-4) and IgA Autoantibody Profiles Against Muscle-Specific Kinase in a Greek Cohort.

IgG Subclass (IgG1-4) and IgA Autoantibody Profiles Against Muscle-Specific Kinase in a Greek Cohort.

Journal: Muscle & nerve

Published: September 05, 2025

Urinary Dysfunction in Myasthenic Syndromes: A Scoping Review of Clinical Features and Treatment-Related Associations.

Urinary Dysfunction in Myasthenic Syndromes: A Scoping Review of Clinical Features and Treatment-Related Associations.

Journal: Muscle & nerve

Published: August 29, 2025

Preemptive immunotherapy for fetal acetylcholine receptor antibody disorder (FARAD): from recurrent pregnancy losses to a healthy infant - a case report.

Preemptive immunotherapy for fetal acetylcholine receptor antibody disorder (FARAD): from recurrent pregnancy losses to a healthy infant - a case report.

Journal: Neuromuscular disorders : NMD

Published: August 20, 2025

Brainstem pathology in anti-IgLON5 disease: new insights into early events and tau progression.

Brainstem pathology in anti-IgLON5 disease: new insights into early events and tau progression.

Journal: Brain : a journal of neurology

Published: July 14, 2025

Consequences of plectin ablation on the various intermediate filament systems in skeletal muscle.

Consequences of plectin ablation on the various intermediate filament systems in skeletal muscle.

Journal: European journal of cell biology

Published: March 07, 2025

Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathy.

Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathy.

Journal: Acta neuropathologica

Published: April 16, 2024

Acetylcholinesterase inhibitors are ineffective in MuSK-antibody positive myasthenia gravis: Results of a study on 202 patients.

Acetylcholinesterase inhibitors are ineffective in MuSK-antibody positive myasthenia gravis: Results of a study on 202 patients.

Journal: Journal of the neurological sciences

Published: February 06, 2024

HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 disease.

HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 disease.

Journal: Frontiers in immunology

Published: January 25, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026